首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Simultaneous determination of loxoprofen and its diastereomeric alcohol metabolites in human plasma and urine by a simple HPLC-UV detection method.
【24h】

Simultaneous determination of loxoprofen and its diastereomeric alcohol metabolites in human plasma and urine by a simple HPLC-UV detection method.

机译:通过简单的HPLC-UV检测方法同时测定人血浆和尿液中洛索洛芬及其非对映异构醇代谢物。

获取原文
获取原文并翻译 | 示例
           

摘要

A simple, reliable HPLC-UV detection method was developed for the simultaneous determination of loxoprofen and its metabolites (i.e. trans- and cis-alcohol metabolites), in human plasma and urine samples. The method involves the addition of a ketoprofen (internal standard) solution in methanol, zinc sulfate solution and acetonitrile to plasma and urine samples, followed by centrifugation. An aliquot of the supernatant was evaporated to dryness, and the residue reconstituted in a mobile phase (acetonitrile:water=35:65 v/v, pH 3.0). An aliquot of the solution was then directly injected into the HPLC system. Separations were performed on octadecylsilica column (250x4.5 mm, 5 microm) with a guard column (3.2x1.5 cm, 7 microm) at ambient temperature. Loxoprofen and the metabolites in the eluent were monitored at 220 nm (a.u.f.s. 0.005). Coefficients of variations (CV%) and recoveries for loxoprofen and its metabolites were below 10 and over 96%, respectively, in the 200 approximately 15000 ng ml(-1) range for plasma and 500 approximately 50000 ng ml(-1) range for urine. Calibration curves for all the compounds in the plasma and urine were linear over the above-mentioned concentration ranges with a common correlation coefficient of 0.999. The detection limit of the present method was 100 ng for all the compounds. These results indicate that the present method is very simple and readily applicable to routine bioavailability studies of these compounds with an acceptable sensitivity.
机译:开发了一种简单,可靠的HPLC-UV检测方法,用于同时测定人血浆和尿液样品中洛索洛芬及其代谢产物(即反式和顺式醇代谢物)。该方法包括向血浆和尿液样品中添加酮洛芬(内标)的甲醇溶液,硫酸锌溶液和乙腈,然后离心。将上清液的等分试样蒸发至干,并将残余物在流动相(乙腈:水= 35∶65 v / v,pH 3.0)中重构。然后将等分溶液直接注入HPLC系统。在环境温度下,在十八烷基硅胶柱(250x4.5 mm,5微米)和保护柱(3.2x1.5 cm,7微米)上进行分离。在220 nm(a.u.f.s. 0.005)处监测洛索洛芬和洗脱液中的代谢产物。洛索洛芬及其代谢产物的变异系数(CV%)和回收率分别低于10和96%以上,血浆200约为15000 ng ml(-1)范围内,血浆500约为50000 ng ml(-1)范围内。尿。血浆和尿液中所有化合物的校准曲线在上述浓度范围内均为线性,共同相关系数为0.999。对于所有化合物,本方法的检测限为100 ng。这些结果表明,本方法非常简单并且易于以可接受的灵敏度应用于这些化合物的常规生物利用度研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号